Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

0.9200 +0.0300 (+3.37%)
Official Closing Price Updated: 4:10 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Hldgs Inc

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the... 
Via Benzinga
3 Meme Stocks to Sell in May Before They Crash & Burn
Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends. 
Via InvestorPlace
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities. 
Via InvestorPlace
Ginkgo Bioworks: Buy, Sell, or Hold?
This company has a long way to go before investors will see rewards. 
Via The Motley Fool
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering. 
Via InvestorPlace
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock?
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze. 
Via InvestorPlace
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Via Benzinga
Is Ginkgo Bioworks Stock a Buy?
There's a lot to like about this business, but it's still a risky bet. 
Via The Motley Fool
Why Ginkgo Bioworks Stock Is Sinking Today
There wasn't much to like in Ginkgo's Q4 update. 
Via The Motley Fool
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Earnings Outlook For Ginkgo Bioworks Holdings
Via Benzinga
Is Ginkgo Bioworks Stock a Buy Now?
Ginkgo Bioworks says it is experiencing strong growth from its biopharma customers. 
Via The Motley Fool
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
The collaboration could help solve challenges for both businesses. 
Via The Motley Fool
What's Going On With Ginkgo Bioworks Stock?
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the... 
Via Benzinga
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These stocks, a bargain today, are players to hold on to for the long term. 
Via The Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
They might not be profitable yet, but they're swinging for the fences. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
These stocks could rocket higher, but they also present significant risks. 
Via The Motley Fool
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
There are some great companies at attractive prices in the lucrative pharmaceutical space. 
Via The Motley Fool
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
It isn't ready for membership today, but it could have a path in the future. 
Via The Motley Fool
S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday?
March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Ginkgo Bioworks Stock Is Down After Earnings
Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment and the impact of Cell Engineering downstream value share from equity... 
Via Benzinga
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value
These two businesses have viable paths to making investors richer -- possibly soon. 
Via The Motley Fool
7 Stocks Cathie Wood Is Still Loading Up On in Q1
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future. 
Via InvestorPlace
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential
These two platform biotechs could revolutionize the field of biologically based products. 
Via The Motley Fool
Cathie Wood Just Bought These 3 Biotech Stocks. Should You?
They aren't all long shots, but they're all innovative. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.